Intestinal Disorders News

Fecal microbiota transplantation could help restore the pathological imbalances within the resident microbes caused by enterocolitis, according to findings published in BMC Infectious Diseases.

Antibiotic treatment did not meet criteria for noninferiority compared with appendectomy for patients with uncomplicated appendicitis, although most who received antibiotics did not require surgery or have significant complications if they did, according to new research data.

The FDA has granted orphan drug designation to NTRA-9620, a new orally administered treatment for short bowel syndrome in patients of all ages, the manufacturer announced today.

Venous thromboembolism incidence has remained low and largely unchanged following colorectal surgery despite an increase in pre- and post-surgical prevention strategies, according to study results.

WASHINGTON — William D. Chey, MD, from the University of Michigan Health System discusses several abstracts he presented at DDW 2015 with data on new drug treatments for irritable bowel syndrome.

WASHINGTON – Two studies presented during DDW 2015 showed safety and efficacy of Entyvio used in pediatric patients with a range of inflammatory bowel diseases.

WASHINGTON — A novel monoclonal antibody was associated with improved outcomes in a cohort of patients with active Crohn’s disease, according to findings presented here.

WASHINGTON — For patients who have ongoing complaints after an episode of diverticulitis or frequent recurrences, elective resection improved quality of life compared with conservative management, according to data from a late-breaker abstract presented at Digestive Disease Week.

WASHINGTON — Radiofrequency ablation has emerged as possibly being a more effective and tolerable option compared to argon plasma coagulation in the treatment of gastric antral vascular ectasia according to findings from Yale University presented at Digestive Disease Week.

Researchers have proposed that a “treat-to-target” strategy for the management of inflammatory bowel disease may lead to an improved doctor–patient relationship.